Aims: Sarcopenia is an emerging risk factor for cardiovascular disease (CVD). However, previous studies did not take into consideration the cardiovascular impact of the changes in sarcopenia status. We investigated the relationship between changes in sarcopenia status and incident CVD.
Methods: Participants from two prospective cohorts: the China Health and Retirement Longitudinal Study (CHARLS) and the Health and Retirement Study (HRS) were included. Changes in sarcopenia status were assessed by sarcopenia status at the initial two surveys. CVD was ascertained by self-reported physician-diagnosed heart disease or stroke.
Results: A total of 6,608 and 4,316 adults from CHARLS (mean age: 59.2 years, female: 53.6%) and HRS (mean age: 63.2 years, female: 60.2%) were analyzed, with a median follow-up of 5.0 years and 7.5 years, respectively. Meta-analysis showed a significant relationship between sarcopenia and CVD risk. Bidirectional MR analysis supported the robustness and causality, and no reverse association was found between CVD and sarcopenia. Compared with stable no sarcopenia participants, multivariable-adjusted incidence rate ratio (IRR) and 95% confidence interval (95% CI) for incident CVD in those who progressed from no sarcopenia to possible sarcopenia/sarcopenia were 1.29 (1.02-1.64) and 1.39 (1.11-1.74) in both cohorts. In contrast, sarcopenia participants who recovered to no sarcopenia/possible sarcopenia had lower incidence of CVD (CHARLS, IRR 0.61, 95% CI 0.43-0.87; HRS, IRR 0.20, 95% CI 0.11-0.39) than stable sarcopenia participants did.
Conclusions: The progression of sarcopenia status increases the risk of CVD, while the recovery of sarcopenia status reduces the risk of incident CVD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/eurjpc/zwaf115 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gender Differences in the Prevalence and Associated Factors of Sarcopenia Among Maintenance Haemodialysis Patients in Vietnam.
Nephrology (Carlton)
March 2025
Department of Internal Medicine, Hanoi Medical University, Hanoi, Vietnam.
Aim: The prevalence and associated factors of dialysis-related sarcopenia could vary greatly according to gender. This study aimed to determine the prevalence of sarcopenia in haemodialysis patients according to gender and to assess some factors related to sarcopenia.
Methods: A cross-sectional study was conducted in maintenance haemodialysis patients.
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series.
J Cachexia Sarcopenia Muscle
April 2025
Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Background: In patients receiving anti-cancer treatment, cachexia results in poorer oncological outcomes. However, there is limited understanding and no systematic review of oncological endpoints in cancer cachexia (CC) trials. This review examines oncological endpoints in CC clinical trials.
View Article and Find Full Text PDFRisk factors and an optimized prediction model for urosepsis in diabetic patients with upper urinary tract stones.
Sci Rep
March 2025
Department of Urology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
To identify independent risk factors for urosepsis in diabetic patients with upper urinary tract stones (UUTS) and develop a prediction model to facilitate early detection and diagnosis, we retrospectively reviewed medical records of patients admitted between January 2020 and June 2023. Patients were divided based on the quick Sequential Organ Failure Assessment (qSOFA) score. The least absolute shrinkage and selection operator (LASSO) regression analysis was used for variable selection to form a preliminary model.
View Article and Find Full Text PDFCross-sectional associations between clinical biochemistry and nutritional biomarkers and sarcopenic indices of skeletal muscle in the Baltimore Longitudinal Study of Aging.
J Nutr
March 2025
Norwich Medical School, University of East Anglia, Norwich, UK; Centre for Population Health Research, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK; Norwich Epidemiology Centre, Faculty of Medicine and Health Sciences, Population Health, University of East Anglia, Norwich, UK.
Background: Investigating relationships between nutritional and clinical biochemistry biomarkers and skeletal muscle mass, strength and function (sarcopenic indices) may: (i) highlight micronutrients of interest for potential preventive or treatment strategies for sarcopenia, or (ii) highlight biomarkers that may be useful for identifying individuals at risk of sarcopenia.
Objectives: Investigate associations between nutritional biomarkers (vitamin D, vitamin B12, folate, magnesium, potassium, calcium, iron), clinical biomarkers (haemoglobin, ferritin, albumin, creatinine, HbA1c) and sarcopenic indices (appendicular lean mass (ALM), height-adjusted ALM (ALM), fat-free mass percentage of body weight (FFM%), extended short physical performance battery score (SPPB), and height-adjusted hand grip strength (HGS) and knee extension concentric (KEC) and isometric (KEI) strength) in men and women.
Design: Using multivariable linear regression analysis we investigated cross-sectional associations between biomarkers and sarcopenic indices in data collected from 1,761 participants (age 22-103 years) from the Baltimore Longitudinal Study of Aging (BLSA).
The evidence and impact of deprescribing on sarcopenia parameters: a systematic review.
BMC Geriatr
March 2025
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Background: Polypharmacy (concomitant prescription of ≥ 5 medications) affects a third of older people, and evidence suggests an association with sarcopenia (loss of skeletal muscle mass/quality, muscle strength, and/or physical performance). As such, deprescribing has been recommended in routine management of sarcopenia, however it's unknown whether deprescribing is beneficial. This systematic review aimed to understand effects of deprescribing on sarcopenia parameters in older adults.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!